Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden
| Autor: | Åsa Ericsson, Johan Jendle, Emelie Andersson, Nino Hallén, Katarina Steen Carlsson, Peter Lindgren, Desirée Thielke, Sofie Persson |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty Insurance disability Endocrinology Diabetes and Metabolism Population 030209 endocrinology & metabolism Type 2 diabetes Article 03 medical and health sciences 0302 clinical medicine Cost of Illness Diabetes complications Ambulatory care Diabetes mellitus Sick leave Health care Internal Medicine medicine Humans 030212 general & internal medicine education Socioeconomic status Aged Sweden education.field_of_study business.industry Diabetes mellitus type 2 Health Care Costs Middle Aged medicine.disease Emergency medicine Female Costs and cost analysis Hospital costs business Kidney disease |
| Zdroj: | Diabetologia |
| ISSN: | 1432-0428 0012-186X |
| DOI: | 10.1007/s00125-020-05277-3 |
| Popis: | Aims/hypothesis The risk of complications and medical consequences of type 2 diabetes are well known. Hospital costs have been identified as a key driver of total costs in studies of the economic burden of type 2 diabetes. Less evidence has been generated on the impact of individual diabetic complications on the overall societal burden. The objective of this study was to analyse costs of hospital-based healthcare (inpatient and outpatient care) and work absence related to individual macrovascular and microvascular complications of type 2 diabetes in Sweden in 2016. Methods Data for 2016 were retrieved from a Swedish national retrospective observational database cross-linking individual-level data for 1997–2016. The database contained information from population-based health, social insurance and socioeconomic registers for 392,200 people with type 2 diabetes and matched control participants (5:1). Presence of type 2 diabetes and of diabetes complications were derived using all years, 1997–2016. Costs of hospital-based care and of absence from work due to diabetes complications were estimated for the year 2016. Regression analysis was used for comparison with control participants to attribute absence from work to individual complications, and to account for joint presence of complications. Results Use of hospital care for complications was higher in type 2 diabetes compared with control participants in 2016: 26% vs 12% had ≥1 hospital contact; there were 86,104 vs 24,608 outpatient visits per 100,000 people; and there were 9894 vs 2546 inpatient admissions per 100,000 people (all p p Conclusions/interpretation The economic burden of complications in type 2 diabetes is substantial. Costs of absence from work in this study were found to be greater than of hospital-based care, highlighting the need for considering treatment consequences in a societal perspective in research and policy. Graphical abstract |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink